Sasha Cucuz - 10 Dec 2024 Form 3 Insider Report for Neuronetics, Inc. (STIM)

Role
Director
Signature
/s/ Patrick Devine, as Attorney-in-Fact
Issuer symbol
STIM
Transactions as of
10 Dec 2024
Net transactions value
$0
Form type
3
Filing time
19 Dec 2024, 17:00:04 UTC
Previous filing
02 Jan 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding STIM Common Stock 2,042 10 Dec 2024 By Greybrook Realty Partners Inc. F1
holding STIM Common Stock 516,084 10 Dec 2024 By Greybrook Health Inc. F1
holding STIM Common Stock 12,500 10 Dec 2024 Direct F2
holding STIM Common Stock 1,375,000 10 Dec 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) the date of the Issuer's annual stockholder meeting or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date. Each RSU represents a contingent right to recieve one share of the Issuer's common stock.